美国褪黑素补充剂使用与2型糖尿病及心血管疾病风险:三项前瞻性队列研究的启示
该研究基于美国三项前瞻性队列(护士健康研究、卫生专业人员随访研究、护士健康研究II),纳入中老年男女,评估定期使用褪黑素补充剂与2型糖尿病及心血管疾病发病风险的关联。汇总分析显示,与不使用褪黑素者相比,使用者心血管疾病风险(HR 0.94,95%CI 0.83-1.06,p=0.32)和2型糖尿病风险(HR 0.98,95%CI 0.86-1.12,p=0.80)均无显著差异。在女性护士中,褪黑素使用似乎减弱长期轮班工作(>5年)与心血管疾病风险的正向关联(交互作用p=0.013)。
要点
- 在中老年男女中,自我报告的褪黑素补充剂使用与2型糖尿病风险无显著关联(HR 0.98,95%CI 0.86-1.12)。
- 褪黑素补充剂使用与心血管疾病风险无显著关联(HR 0.94,95%CI 0.83-1.06)。
- 在女性护士中,褪黑素使用似乎减弱长期轮班工作(>5年)与心血管疾病风险的正向关联(交互作用p=0.013)。
核心结论
- 在中老年男女中,自我报告的褪黑素补充剂使用与2型糖尿病或心血管疾病风险无显著关联。
- 作者认为需进一步研究以评估褪黑素补充剂使用是否能减轻轮班夜班工作相关的2型糖尿病和心血管疾病潜在风险。
研究设计与样本
- 研究纳入美国三项前瞻性队列:护士健康研究(仅女性)、卫生专业人员随访研究(仅男性)和护士健康研究II(仅女性)。
- 纳入基线无癌症诊断且回答了褪黑素补充剂使用问题(是或否)的女性(25-55岁)和男性(45-75岁)。
- 主要分析排除基线流行心血管疾病和基线流行2型糖尿病者。
- 主要结局为心血管疾病和2型糖尿病发病率;次要分析按护士健康研究和护士健康研究II中轮班夜班工作持续时间分层。
主要发现
- 心血管疾病分析纳入护士健康研究67202名女性(随访1998-2019,基线平均年龄63.6岁[SD 7.1])、卫生专业人员随访研究26629名男性(1998-2020,62.9岁[8.8])和护士健康研究II 65241名女性(2003-19,48.2岁[4.7])。
- 2型糖尿病随访时间:护士健康研究1998年至2021年6月30日;护士健康研究II 2003年至2023年1月31日;卫生专业人员随访研究1998年至2020年1月31日。
- 研究队列中褪黑素补充剂使用近几十年翻倍,从1998-2007年的不足2%升至2014-15年的4%或更高(男性4.0%,女性5.3%)。
- 随访2 609 068人年期间记录16917例 incident 心血管疾病事件,随访2 701 830人年期间记录12730例 incident 2型糖尿病病例。
- 三项队列汇总分析中,与不使用褪黑素者相比,使用者心血管疾病的多变量校正HR为0.94(95%CI 0.83-1.06,p=0.32),2型糖尿病为0.98(95%CI 0.86-1.12,p=0.80)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者认为需进一步研究以评估褪黑素补充剂使用是否能减轻轮班夜班工作相关的2型糖尿病和心血管疾病潜在风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Use of melatonin supplements has been increasing substantially in both children and adults in the USA; however, their long-term cardiometabolic effects remain unclear. We aimed to assess the associations between regular use of melatonin supplements and the risk of developing type 2 diabetes or cardiovascular disease in adults. METHODS: In this study, we included individuals from three US cohorts: the Nurses' Health Study (women only), the Health Professionals Follow-up Study (men only), and the Nurses' Health Study II (women only). Women aged 25-55 years and men aged 45-75 years at baseline, who had no diagnosis of cancer at baseline, and who responded to the question about melatonin supplement use (yes or no) were included. We excluded baseline prevalent cardiovascular disease and baseline prevalent type 2 diabetes for the main analyses. The main outcomes were cardiovascular disease and type 2 diabetes incidence. In secondary analyses, we stratified by duration of rotating night shift work in the Nurses' Health Study and Nurses' Health Study II to examine whether the associations with melatonin supplement use differed by rotating night shift work. FINDINGS: For the cardiovascular disease analysis, we included 67 202 women from the Nurses' Health Study (follow-up 1998-2019, mean age at baseline: 63·6 years [SD 7·1]), 26 629 men from the Health Professionals Follow-up Study (1998-2020, 62·9 years [8·8], and 65 241 women from the Nurses' Health Study II (2003-19, 48·2 years [4·7]). Follow-up for incident type 2 diabetes was from 1998 to June 30, 2021, for the Nurses' Health Study; 2003 to Jan 31, 2023, for the Nurses' Health Study II; and from 1998 to Jan 31, 2020, for the Health Professionals' Follow-up Study. Melatonin supplement use in the study cohorts doubled over recent decades from less than 2% in 1998-2007 to 4% or higher in 2014-15 (4·0% in men and 5·3% in women). We documented 16 917 incident cardiovascular disease events during 2 609 068 person-years of follow-up and 12 730 incident cases of type 2 diabetes during 2 701 830 person-years of follow-up. In a pooled analysis of the three cohorts, comparing users with non-users of melatonin supplements, the pooled multivariable-adjusted hazard ratios were 0·94 (95% CI 0·83-1·06, p=0·32) for cardiovascular disease and 0·98 (0·86-1·12, p=0·80) for type 2 diabetes. In secondary analyses, melatonin supplement use appeared to attenuate the positive association between long-term shift work (>5 years) and risk of cardiovascular disease (pinteraction=0·013) among the female nurses. INTERPRETATION: With up to 23 years of follow-up of three large prospective cohorts of middle-aged and older men and women, self-reported melatonin supplement use was not associated with risk of type 2 diabetes or cardiovascular disease. Further research is warranted to assess if melatonin supplement use could mitigate the potential risks of type 2 diabetes and cardiovascular disease associated with rotating night shift work. FUNDING: US National Institutes of Health.
引用
- Li Y, Huang T, Redline S, et al. Use of melatonin supplements and risk of type 2 diabetes and cardiovascular diseases in the USA: insights from three prospective cohort studies. Lancet Diabetes Endocrinol. 2024. PMID: 38710189. doi:10.1016/S2213-8587(24)00096-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。